United States:
COVID-19 Key EU Developments, Policy & Regulatory Update No. 24
25 October 2020
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
This regular update (no. 24 | 13 October 2020) covers key
regulatory EU developments related to the evolving COVID-19
situation (Antitrust & State Aid; Trade/Export Controls;
Medicines, Medical Devices and Personal Protective Equipment; and
Cybersecurity, Privacy & Data Protection).
COVID19 KEY EU DEVELOPMENTS No 24 13 Oct
2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Coronavirus (COVID-19) from United States
CCPA For Dummies
Klein Moynihan Turco LLP
Over the past three years, we have blogged extensively about the California Consumer Privacy Act ("CCPA" or the "Act") and the multiple amendments that have been made to it.
IRS Finalizes Carried Interest Regulations
Cadwalader, Wickersham & Taft LLP
On January 7, 2021, the IRS and Treasury issued final regulations under section 1061 of the tax code. Section 1061 imposes a three-year holding period as a precondition to recognizing long-term...
